Soluble CD40 Ligand in Aspirin-Treated Patients Undergoing Cardiac Catheterization

about

Impact of CYP2C19 Variants on Clinical Efficacy of Clopidogrel and 1-Year Clinical Outcomes in Coronary Heart Patients Undergoing Percutaneous Coronary Intervention.

P2860

Q36216896-6E8BA78F-E652-42F4-A9BC-A9041E796587

P2860

Soluble CD40 Ligand in Aspirin-Treated Patients Undergoing Cardiac Catheterization

Item

http://www.wikidata.org/entity/Q35735264

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Soluble CD40 Ligand in Aspirin-Treated Patients Undergoing Cardiac Catheterization

@ast

Soluble CD40 Ligand in Aspirin-Treated Patients Undergoing Cardiac Catheterization

@en

type

Item

label

Soluble CD40 Ligand in Aspirin-Treated Patients Undergoing Cardiac Catheterization

@ast

Soluble CD40 Ligand in Aspirin-Treated Patients Undergoing Cardiac Catheterization

@en

prefLabel

Soluble CD40 Ligand in Aspirin-Treated Patients Undergoing Cardiac Catheterization

@ast

Soluble CD40 Ligand in Aspirin-Treated Patients Undergoing Cardiac Catheterization

@en

P1476

Soluble CD40 Ligand in Aspirin-Treated Patients Undergoing Cardiac Catheterization

@en

P2093

Alan D Michelson

http://www.w3.org/2001/XMLSchema#string

Andrew L Frelinger

http://www.w3.org/2001/XMLSchema#string

P2860

CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells

Soluble CD40 ligand, soluble P-selectin, interleukin-6, and tissue factor in diabetes mellitus: relationships to cardiovascular disease and risk factor intervention

Impact of clopidogrel on suppression of circulating levels of soluble CD40 ligand in patients with unstable angina undergoing coronary stenting

Effects of clopidogrel on soluble CD40 ligand and on high-sensitivity C-reactive protein in patients with stable coronary artery disease

Clopidogrel improves systemic endothelial nitric oxide bioavailability in patients with coronary artery disease: evidence for antioxidant and antiinflammatory effects

Residual arachidonic acid-induced platelet activation via an adenosine diphosphate-dependent but cyclooxygenase-1- and cyclooxygenase-2-independent pathway: a 700-patient study of aspirin resistance

Indices of platelet activation and the stability of coronary artery disease

Upregulation of CD40-CD40 ligand (CD154) in patients with acute cerebral ischemia.

Cardiopulmonary bypass induces release of soluble CD40 ligand.

Concurrent evaluation of novel cardiac biomarkers in acute coronary syndrome: myeloperoxidase and soluble CD40 ligand and the risk of recurrent ischaemic events in TACTICS-TIMI 18.

P304

e0134599

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0134599

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Thomas Gremmel

P577

2015-08-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

281538232

http://www.w3.org/2001/XMLSchema#string

P698

26237513

http://www.w3.org/2001/XMLSchema#string

P921

aspirin

catheterization

P932

4523196

http://www.w3.org/2001/XMLSchema#string

Soluble CD40 Ligand in Aspirin-Treated Patients Undergoing Cardiac Catheterization

about

P2860

P2860

Soluble CD40 Ligand in Aspirin-Treated Patients Undergoing Cardiac Catheterization

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P5875

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P5875

P698

P921

P932